TCIRG1 encodes the a3 subunit of vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump complex essential for acidifying intracellular compartments 1. As an integral component of the V0 membrane domain, TCIRG1 is primarily localized to lysosomes in mammalian cells, where it regulates late phagosome-lysosomal fusion and maintains lysosomal acidification 1. Defective TCIRG1 impairs phagosome maturation, autophagy, and cellular degradation pathways critical for immune cell function 1. Biallelic TCIRG1 mutations cause autosomal recessive osteopetrosis (ARO), affecting >50% of cases, due to osteoclast dysfunction and impaired bone resorption 23. The disease manifests as dense, fragile bone with severe complications including hepatosplenomegaly, thrombocytopenia, visual/hearing impairment, and infections 4. Heterozygous TCIRG1 variants also cause severe congenital neutropenia (SCN), with reduced TCIRG1 protein levels in affected individuals 5. Computational studies identify highly conserved protein domains critical for V-ATPase function; mutations in these regions substantially destabilize protein structure and impair catalytic activity 6. Gene therapy approaches using lentiviral vectors demonstrate post-transcriptional regulation preventing pathological overexpression, offering potential therapeutic strategies for osteopetrosis 7.